Calcium-activated potassium channels contribute to human skeletal muscle microvascular endothelial dysfunction related to cardiopulmonary bypass

Surgery

Volumn 144, Issue 2, 2008, Pages 239-244

  Liu, Yuhong ^a   Sellke, Eric W ^a   Feng, Jun ^a   Clements, Richard T ^a   Sodha, Neel R ^a   Khabbaz, Kamal R ^a   Senthilnathan, Venkatachalam ^a   Alper, Seth L ^a   Sellke, Frank W ^a  

^a Department of Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 HYDROXY 5 TRIFLUOROMETHYLPHENYL) 5 TRIFLUOROMETHYL 2(3H) BENZIMIDAZOLONE; ADENOSINE DIPHOSPHATE; CALCIUM ACTIVATED POTASSIUM CHANNEL; NITROPRUSSIDE SODIUM; NS 309; SUBSTANCE P; VASODILATOR AGENT;

ADULT; AGED; ARTERIOLE; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FEMALE; FLOW RATE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MALE; PRIORITY JOURNAL; SKELETAL MUSCLE;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; AGED; APAMIN; BENZIMIDAZOLES; CARDIOPULMONARY BYPASS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INDOLES; INTERMEDIATE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; MALE; MUSCLE, SKELETAL; OXIMES; PEPTIDES; POTASSIUM CHANNELS; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; PYRAZOLES; SMALL-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; VASOCONSTRICTOR AGENTS; VASODILATION;

EID: 47749106773     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2008.03.032     Document Type: Article

References (11)

1. Ruel M., Khan T.A., Voisine P., Bianchi C., and Sellke F.W. Vasomotor dysfunction after cardiac surgery. Eur J Cardiothorac Surg 26 (2004) 1002-1014
2. Wang S.Y., Stamler A., Li J., Johnson R.G., and Sellke F.W. Decreased myogenic reactivity in skeletal muscle arterioles after hypothermic cardiopulmonary bypass. J Surg Res 69 (1997) 40-44
3. Stamler A., Wang S.Y., Aguirre D.E., Johnson R.G., and Sellke F.W. Cardiopulmonary bypass alters vasomotor regulation of the skeletal muscle microcirculation. Ann Thorac Surg 64 (1997) 460-465
4. Khan T.A., Bianchi C., Araujo E.G., Ruel M., Voisine P., Li J., et al. Cardiopulmonary bypass reduces peripheral microvascular contractile function by inhibition of mitogen-activated protein kinase activity. Surgery 134 (2003) 247-254
5. Ledoux J., Werner M.E., Brayden J.E., and Nelson M.T. Calcium-activated potassium channels and the regulation of vascular tone. Physiology 21 (2006) 69-78
6. Feng J., Sellke M.E., Ramlawi B., Boodhwani M., Clements R., Li J.Y., et al. Bradykinin induces microvascular preconditioning via opening of calcium-activated potassium channels. Surgery 140 (2006) 192-197
7. Wei A.D., Gutman G.A., Aldrich R., Chandy K.G., Grissmer S., and Wulff H. International Union of Pharmacology. LII. Nomenclature and molecular relationships of calcium-activated potassium channels. Pharmacol Rev 5 (2005) 463-472
8. 2+-activated potassium channel Kcnn4. J Biol Chem 279 (2004) 47681-47687
9. Ca channel in smooth muscle. Trends Pharmacol Sci 22 (2001) 505-512
10. + channel activity in smooth muscle of human coronary arterioles. Circ Res 9 (2002) 1070-1076
11. Liu Y.H., Feng J., Sodha N.R., Khabbaz K.R., Senthilnathan V., Alper S.L., et al. Calcium activated potassium channels contribute to human coronary microvascular dysfunction after cardioplegia arrest. Circulation 116 Suppl II (2007) II-324